A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production.
about
Transcriptome Profiling Reveals Disruption of Innate Immunity in Chronic Heavy Ethanol Consuming Female Rhesus MacaquesInflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.Structures of the inactive and active states of RIP2 kinase inform on the mechanism of activation.Kinase targets in CNS drug discovery.Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia.LRRK2 and the Immune System.The small molecule that packs a punch: ubiquitin-mediated regulation of RIPK1/FADD/caspase-8 complexes.Posttranslational Modification as a Critical Determinant of Cytoplasmic Innate Immune Recognition.The nasal methylome and childhood atopic asthma.A NODding acquaintance with ER stressSynthetic Biology Reveals the Uniqueness of the RIP Kinase Domain.Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases.Readily Removable Directing Group Assisted Chemo- and Regioselective C(sp(3))-H Activation by Palladium Catalysis.RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis.Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease.Pyridine-enabled copper-promoted cross dehydrogenative coupling of C(sp2)-H and unactivated C(sp3)-H bonds.Unique BIR domain sets determine inhibitor of apoptosis protein-driven cell death and NOD2 complex signal specificityIdentification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel
P2860
Q27334505-B2CCEA24-6C0B-4929-B5CA-46C05E194181Q36084130-BFAF2B8D-BE4E-451D-B67D-BAC6625B238AQ36381630-9AD757A5-D072-4AC2-9ABE-8344BABE1CC0Q38760031-7843517F-5D4E-4015-BBDF-E502F3069EC7Q38796867-75097B02-6AE3-4A6A-B9FE-8249DAAD7603Q39206438-9481DB95-9B19-46BD-8664-9A76C991FE02Q39346095-7ACA44A9-9C44-4BFC-AB3E-6E8F9AB225CDQ39374120-679EF21D-455F-48A9-8877-733923BB7605Q40505147-D506E4C2-81BF-4B7D-B975-998329D0561CQ41786319-8BB1818C-D74C-42AF-8361-F2F04957FDCBQ42784465-BBB2B59A-ED8D-4C05-9044-43C3D4943477Q45952614-FF185E79-ED1B-4FFC-B137-5C86F4789B71Q50246925-00EEAC9A-4FF9-4321-81D1-D7DEBA11BB2DQ54976875-5F3BC300-6B3E-4EDB-AF09-3E3277FB287FQ55154729-0A40A747-9656-430C-A2B3-3B247A91567EQ55267115-1ED8B12F-5104-4DEC-89B5-7ADC24D83254Q57460035-4EE5304C-8990-4908-AA3F-1E1A4904B21BQ57821196-13F5FD93-22F2-4FB4-A8AD-0F57F7AFB461
P2860
A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A RIPK2 inhibitor delays NOD s ...... lammatory cytokine production.
@en
A RIPK2 inhibitor delays NOD s ...... lammatory cytokine production.
@nl
type
label
A RIPK2 inhibitor delays NOD s ...... lammatory cytokine production.
@en
A RIPK2 inhibitor delays NOD s ...... lammatory cytokine production.
@nl
prefLabel
A RIPK2 inhibitor delays NOD s ...... lammatory cytokine production.
@en
A RIPK2 inhibitor delays NOD s ...... lammatory cytokine production.
@nl
P2093
P2860
P50
P356
P1476
A RIPK2 inhibitor delays NOD s ...... lammatory cytokine production.
@en
P2093
Aleksandra Bankovacki
Andrew I Webb
Berthe K Fiil
Che A Stafford
David C S Huang
Guillaume Lessene
Hendrik Falk
Hyun-Ja Ko
James E Vince
P2860
P2888
P356
10.1038/NCOMMS7442
P407
P50
P577
2015-03-17T00:00:00Z
P6179
1016434672